[go: up one dir, main page]

UY32127A - Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación - Google Patents

Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación

Info

Publication number
UY32127A
UY32127A UY0001032127A UY32127A UY32127A UY 32127 A UY32127 A UY 32127A UY 0001032127 A UY0001032127 A UY 0001032127A UY 32127 A UY32127 A UY 32127A UY 32127 A UY32127 A UY 32127A
Authority
UY
Uruguay
Prior art keywords
powder
reduced
processes
containing nicotine
preparation procedures
Prior art date
Application number
UY0001032127A
Other languages
English (en)
Inventor
Roehrich Tillmann
Original Assignee
Siegfried Generics Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Generics Int Ag filed Critical Siegfried Generics Int Ag
Publication of UY32127A publication Critical patent/UY32127A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un granulado que contiene nicotina, reducido en polvo, que comprende una mezcla homogénea de nicotina o un derivado de nicotina farmacéuticamente aceptable y un excipiente. El granulado tiene un tamaño de partícula de al menos 150 um. Método para la preparación de un granulado que contiene nicotina para la preparación de productos farmacéuticos.
UY0001032127A 2008-09-17 2009-09-17 Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación UY32127A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08016336A EP2177213B1 (en) 2008-09-17 2008-09-17 Nicotine-containing granulate

Publications (1)

Publication Number Publication Date
UY32127A true UY32127A (es) 2010-04-30

Family

ID=40091848

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032127A UY32127A (es) 2008-09-17 2009-09-17 Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación

Country Status (17)

Country Link
US (1) US10413512B2 (es)
EP (1) EP2177213B1 (es)
AR (1) AR073604A1 (es)
AU (1) AU2009294964B2 (es)
CA (1) CA2734402C (es)
DK (1) DK2177213T3 (es)
ES (1) ES2401912T3 (es)
HR (1) HRP20130161T1 (es)
MX (1) MX2011002696A (es)
NZ (1) NZ591198A (es)
PA (1) PA8842701A1 (es)
PL (1) PL2177213T3 (es)
PT (1) PT2177213E (es)
SI (1) SI2177213T1 (es)
UY (1) UY32127A (es)
WO (1) WO2010031536A1 (es)
ZA (1) ZA201101123B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2198865E (pt) * 2008-12-19 2012-02-07 Siegfried Ltd Produto que contém nicotina
BR112015021630A2 (pt) * 2013-03-07 2017-07-18 Amneal Pharmaceuticals Llc estabilização de fármacos sensíveis à umidade
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
WO2015051308A1 (en) * 2013-10-03 2015-04-09 Altria Client Services Inc. Lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US12274276B2 (en) 2013-10-03 2025-04-15 Altria Client Services Llc Dissolvable-chewable tablet
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
EP3349733A1 (de) * 2015-09-14 2018-07-25 Merck Patent GmbH Formulierung mit kontrollierter, verzögerter wirkstoffreisetzung
US11311623B2 (en) 2016-04-21 2022-04-26 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
US11406630B2 (en) 2017-06-23 2022-08-09 Ncp Nextgen A/S Nicotine pouch
AU2018378648B2 (en) 2017-12-08 2021-06-03 Fertin Pharma A/S Nicotine tablet
WO2019110073A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Solid oral nicotine formulation
EP3720497A1 (en) 2017-12-08 2020-10-14 Fertin Pharma A/S High nicotine concentration
PH12021553026A1 (en) 2019-07-05 2023-08-23 Swedish Match North Europe Ab An oral pouched nicotine product including a filling material comprising nicotine-containing particles
PL3946262T3 (pl) * 2019-08-30 2024-11-25 Evie Sa Wypełnione granulki, sposób ich wytwarzania i ich zastosowania
PL4061155T3 (pl) 2019-11-20 2024-01-29 Swedish Match North Europe Ab Doustny produkt nikotynowy w saszetce, zawierający materiał wypełniający zawierający cząstki nikotyny
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US11672862B2 (en) * 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US20220304366A1 (en) * 2019-12-09 2022-09-29 Nicoventures Trading Limited Oral products with reduced irritation
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US20220313614A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Encapsulated nicotine granules and methods of preparation thereof
US20220313678A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Spray dried nicotine for inclusion in oral products
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
CA3223902A1 (en) 2021-06-25 2022-12-29 Richard Svensson Oral products and method of manufacture
CN114304712A (zh) * 2021-12-17 2022-04-12 深圳市元雾科技有限公司 一种液体高负载的尼古丁口含制品颗粒及其制备方法
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104787B (fi) 1989-06-07 2000-04-14 Xyrofin Oy Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi
SE8904295D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6276917B1 (en) * 1999-01-28 2001-08-21 Botanicals International Powder processing apparatus
FR2792200B3 (fr) * 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
DE19943496C1 (de) 1999-09-10 2001-05-17 Suedzucker Ag Direkt verpressbarer Rohstoff für Komprimate
WO2002076605A1 (de) 2001-03-23 2002-10-03 Symrise Gmbh & Co. Kg Verfahren zur herstellung von einkapselungen
ES2708552T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
WO2008012071A2 (en) 2006-07-24 2008-01-31 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof

Also Published As

Publication number Publication date
SI2177213T1 (sl) 2013-03-29
HRP20130161T1 (hr) 2013-03-31
ZA201101123B (en) 2012-04-25
PT2177213E (pt) 2013-02-21
AU2009294964B2 (en) 2012-12-13
DK2177213T3 (da) 2013-02-11
CA2734402A1 (en) 2010-03-25
PA8842701A1 (es) 2010-04-21
EP2177213B1 (en) 2013-01-02
MX2011002696A (es) 2011-04-05
WO2010031536A1 (en) 2010-03-25
EP2177213A1 (en) 2010-04-21
CA2734402C (en) 2013-05-14
US10413512B2 (en) 2019-09-17
US20110165253A1 (en) 2011-07-07
NZ591198A (en) 2012-03-30
AU2009294964A1 (en) 2010-03-25
AR073604A1 (es) 2010-11-17
PL2177213T3 (pl) 2013-08-30
ES2401912T3 (es) 2013-04-25

Similar Documents

Publication Publication Date Title
UY32127A (es) Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación
UY30537A1 (es) Formulaciones de flibanserina y metodo para fabricarlas
UY39192A (es) Dispersión sólida, proceso para prepararla y forma de dosificación farmacéutica suministrable por vía oral que la comprende
TW201613593A (en) Molecules for administration to ROS1 mutant cancer cells
AR089578A1 (es) Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion
CY1117434T1 (el) Φαρμακευτικες μορφες απιξαμπανης
NO20091501L (no) Farmasoytiske sammensetninger
TWI265812B (en) Pharmaceutical safety dosage forms
HRP20090194T1 (hr) Suha granulirana kompozicija koja sadrži emtricitabin i tenofovir df
DOP2016000159A (es) Formulación compuesta para administración oral que comprende ezetimibe y rosuvastatina.
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
CO6280463A2 (es) Formulaciones farmaceuticas solidas que comprenden bibw 2992
CL2008002394A1 (es) Depsipeptido ciclico, o derivados, inhibidores de calicreína 7, obtenidos desde chondromyces crocatus, metodo de obtencion y usos terapeuticos.
EA025518B9 (ru) Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств
AR062509A1 (es) Proceso para preparar comprimidos de dihidrocloruro de pramipexol
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
AR095159A2 (es) Una composición farmacéutica en forma de cápsula para administración oral
MX340098B (es) Derivados de fenil-isoxazol y procedimiento para la preparacion de los mismos.
AR066000A1 (es) Procedimiento para preparar comprimidos de dihidrocloruro de pramipexol
AR065528A1 (es) Forma de dosificacion que comprende 6-(3- coclobutil -2,3,4,5- tetrahidro -1h - benzo (d) azepin -7-iloxi)-n - metil- nicotinamida , metodo para producirla, su uso para preparar un medicamento y solucion o suspension que los comprende
AU2014226192A8 (en) Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
ECSP16005208A (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido recubierto que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
MX2017015322A (es) Composicion farmaceutica oral de isotretinoin.
CL2016000183A1 (es) Composición farmacéutica anti-tuberculosis estable en una forma de un comprimido redispersable que comprende gránulos de isoniazid y gránulos de rifapentina y su proceso de preparación
BRPI0407850A (pt) processo para fabricação de uma composição farmacêutica contendo o princìpio ativo fenofibrato ou de um de seus derivados, e, comprimido de fenofibrato ou de um de seus derivados

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181114